Top Markets
#1 PulseChain PulseChain +45.01%
#2 RedStone RedStone +16.75%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.64%
#4 Meteora Meteora +9.03%
#5 SkyAI SkyAI +8.73%
#6 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +8.09%
#7 Unit Pump Unit Pump +7.79%
#8 Pump.fun Pump.fun +7.79%
#9 Lighter Lighter +7.66%
#10 Lista DAO Lista DAO +7.22%
Coin of the day
PulseChain PulseChain
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Biora Therapeutics, Inc. Biora Therapeutics, Inc.

Biora Therapeutics, Inc.

PROG
Classement en actions #27722
Biora Therapeutics, Inc., a biotechnology firm, focuses on the development and... Biora Therapeutics, Inc., a biotechnology firm, focuses on the development and commercialization of molecular diagnostic products within the United States. Its research and development efforts include targeted oral delivery systems for biotherapeutics, such as PGN-600, an oral liquid formulation of tofacitinib for ulcerative colitis, and PGN-001, an orally administered variant of adalimumab also targeting ulcerative colitis. Beyond this, the company is advancing systemic oral biotherapeutic delivery, exemplified by PGN-OB, which combines an adalimumab variant with their Oral Biotherapeutics Delivery System (OBDS) for inflammatory conditions, and PGN-OB2, pairing a GLP-1 receptor agonist with the OBDS for Type 2 diabetes. Biora Therapeutics also creates innovative diagnostic tools, including the Recoverable Sampling System – an ingestible smart capsule engineered to autonomously locate, collect, and preserve samples from the GI tract for analysis – and PIL Dx, another ingestible smart capsule designed to sample, measure, and transmit data wirelessly. A collaboration with Ionis Pharmaceuticals is underway to assess the OBDS platform for delivering antisense oligonucleotides. Founded in 2010 as Ascendant MDX, Inc., the company adopted the name Progenity, Inc. in November 2013, prior to becoming Biora Therapeutics, Inc. Its headquarters are located in San Diego, California.
Prix de l'action
$0.8845
Dernière synchronisation: 2022-05-06
Capitalisation boursière
$31.01M
Changement (1 jour)
-3.47%
Changement (1 an)
0.00%
Pays
US
Échange Biora Therapeutics, Inc. (PROG)

Catégorie

Healthcare
EPS pour Biora Therapeutics, Inc. (PROG)
EPS au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Biora Therapeutics, Inc., l’EPS actuel de la société (TTM) est de 0. À la fin de 2026, la société avait un EPS de 0 égal à celui de 2026, qui était de 0.
Historique de l'EPS de Biora Therapeutics, Inc. de 2026 à 2026
EPS à la fin de chaque année
Année EPS Changez
Pas assez de données pour les dates fournies.
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $-7.98 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH